Reaktion #92272

ord-330ca86bbc2e476fa190bb1e289da246

Reaktionsgleichung

CCN(C(C)C)C(C)C
DIEA
CC1(c2cccc(F)c2)CCCN1c1ccn2ncc(N)c2n1
5-(2-(3-fluorophenyl)-2-methylpyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine
O=C(n1ccnc1)n1ccnc1
CDI
Cl.OC1CNC1
azetidin-3-ol hydrochloride
CC1(c2cccc(F)c2)CCCN1c1ccn2ncc(NC(=O)N3CC(O)C3)c2n1
final product
Ausbeute 55.0%
CC1(c2cccc(F)c2)CCCN1c1ccn2ncc(NC(=O)N3CC(O)C3)c2n1
N-(5-(2-(3-fluorophenyl)-2-methylpyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxyazetidine-1-carboxamide
Ausbeute 55.0%

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    workup.STIRRINGThe reaction was stirred for 30 minutes before it
  2. 2
    Einengenwas concentrated
  3. 3
    Sonstigedirectly purified by reverse-phase column chromatography
  4. 4
    Wascheneluting with 0 to 60% acetonitrile/water

Vorschrift

To a DCM (0.7 mL) solution of 5-(2-(3-fluorophenyl)-2-methylpyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine (25 mg, 0.08 mmol) was added CDI (20 mg, 0.12 mmol) at ambient temperature in one portion. After stirring one hour, azetidin-3-ol hydrochloride (20 mg, 0.12 mmol) was added in one portion, followed by addition of DIEA (0.028 mL, 0.16 mmol). The reaction was stirred for 30 minutes before it was concentrated and directly purified by reverse-phase column chromatography, eluting with 0 to 60% acetonitrile/water to yield the final product as a yellowish oil (18 mg, 55% yield). MS (apci) m/z=411.2 (M+H).

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US09447104B2uspto-grants-2016_09